CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-20 | Beetham Thomas W. EVP & Chief Legal Officer | Grant or award · Restricted Share Units | +5,855 | 5,855 | ||
| 2021-03-20 | Beetham Thomas W. EVP & Chief Legal Officer | Grant or award · Restricted Share Units | +4,287 | 4,287 | ||
| 2021-03-16 | Ragosa Mark CFO | Grant or award · Share Option | +20,925 | 20,925 | ||
| 2021-03-16 | Ragosa Mark CFO | Grant or award · Restricted Share Units | +3,488 | 3,488 | ||
| 2021-03-16 | Megna Michael R Chief Accounting Officer | Grant or award · Share Option | +6,195 | 6,195 | ||
| 2021-03-16 | Megna Michael R Chief Accounting Officer | Grant or award · Restricted Share Units | +3,098 | 3,098 | ||
| 2021-03-16 | Paolini John F. SVP & Chief Medical Officer | Grant or award · Share Option | +41,400 | 41,400 | ||
| 2021-03-16 | Paolini John F. SVP & Chief Medical Officer | Grant or award · Restricted Share Units | +6,900 | 6,900 | ||
| 2021-03-16 | Patel Sanj K Chairman & CEO | Grant or award · Share Option | +157,658 | 157,658 | ||
| 2021-03-16 | Patel Sanj K Chairman & CEO | Grant or award · Restricted Share Units | +26,276 | 26,276 | ||
| 2021-03-16 | Beetham Thomas W. EVP & Chief Legal Officer | Grant or award · Share Option | +52,611 | 52,611 | ||
| 2021-03-16 | Beetham Thomas W. EVP & Chief Legal Officer | Grant or award · Restricted Share Units | +8,769 | 8,769 | ||
| 2021-02-10 | Patel Sanj K Chairman & CEO | Option exercise | +1,600 | $1.59 | $3K | 1,600 |
| 2021-02-10 | Patel Sanj K Chairman & CEO | Sale | −1,600 | $23.06 | $37K | 0 |
| 2021-02-10 | Patel Sanj K Chairman & CEO | Sale | −1,137 | $23.07 | $26K | 83,336 |
| 2021-02-10 | Patel Sanj K Chairman & CEO | Option exercise · Share Option | −1,600 | 325,271 | ||
| 2021-02-09 | Patel Sanj K Chairman & CEO | Option exercise | +20,401 | $1.59 | $32K | 20,401 |
| 2021-02-09 | Patel Sanj K Chairman & CEO | Sale | −20,401 | $23.04 | $470K | 0 |
| 2021-02-09 | Patel Sanj K Chairman & CEO | Sale | −23,569 | $23.08 | $544K | 84,473 |
| 2021-02-09 | Patel Sanj K Chairman & CEO | Option exercise · Share Option | −20,401 | 326,871 |
Page 72 of 74 · 1,467 trades